Skip to content

DEVA PHARMA

Active Risk: not assessed Private limited companyfounded 2012active for 14 yearsRidder de Ghellinckstraat 28, 8710 WielsbekeKBO/BCE: BE 0847.315.091
DEVA PHARMA
Financial year 2025
Follow ReportCompare

Annual accounts 2025

abbreviated format, filed on 29-06-2026, 32 days before the deadline
€673,541
▲ 16.0%
€1.0m
▲ 4.5%
€93,689
▲ 44.0%
65.7%
▲ 6.5 percentage points
13.9%
▲ 2.7 percentage points
9.1%
▲ 2.5 percentage points

Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.

Balance sheet

balance sheet total €1.0m on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

65.7%

Higher than 64% of 6,708 companies in 2025.

9.1%

Higher than 68% of 6,673 companies in 2025.

DEVA PHARMA Middle half of the sector 80% of the sector Abbreviated accounts in financial services (NACE 64)

Net result: middle half · Equity: middle half · Balance sheet total: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202120202019201820172016201520142013
Balance sheet: assets
20/58 1.0m980,4781.0m980,333962,528986,827943,865911,136908,494919,400920,205953,718940,640
21/28 905,321907,197908,248909,980911,711901,155900,144900,444906,223912,002917,781924,227903,525
22/27 5,3217,1978,2489,98011,7111,1551444446,22312,00217,78124,2273,525
22 4,9536,4207,8879,35410,820--------
23 -----------252503
24 3687773626268901,1551444446,22312,00217,78123,9753,022
28 900,000900,000900,000900,000900,000900,000900,000900,000900,000900,000900,000900,000900,000
29/58 119,22373,28195,63170,35450,81785,67243,72110,6922,2717,3982,42329,49137,115
40/41 -5,00010,00014,798--5,163---1,58412,100-
40 --10,00014,798------1,58412,100-
41 -5,000----5,163------
54/58 118,74067,75485,14855,10850,17184,58537,4459,6062,2717,39883917,39137,115
490/1 4835284834486451,0871,1131,086-----
Balance sheet: equity and liabilities
10/49 1.0m980,4781.0m980,333962,528986,827943,865911,136908,494919,400920,205953,718940,640
10/15 673,541580,852545,895489,334416,330369,904301,203238,663186,167145,929105,98675,58854,202
10/11 12,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,400
100 ------18,60018,60018,60018,60018,60018,60018,600
101 ------6,2006,2006,2006,2006,2006,2006,200
13 660,330567,650532,606476,046403,146356,762288,062225,522173,026133,17693,17662,17641,176
130/1 --1,8601,8601,8601,860-------
130 ------1,8601,8601,8601,8601,8601,8601,860
1311 --1,8601,8601,8601,860-------
132 -----6,3166,3166,3166,3166,3166,3166,3166,316
133 660,330567,650530,746474,186401,286348,586279,886217,346164,850125,00085,00054,00033,000
14 8108028898887847427427427423544111,012626
16 1,6501,6501,6501,6501,6301,6001,6001,6001,5901,5601,5301,5001,500
160/5 1,6501,6501,6501,6501,6301,6001,6001,6001,5901,5601,5301,5001,500
164/5 1,6501,6501,6501,6501,6301,6001,6001,6001,5901,560---
17/49 349,353397,976456,334489,349544,568615,323641,061670,873720,737771,911812,688876,630884,938
17 33,55977,586120,807163,236205,267244,422282,270318,854357,453397,970443,418493,840515,503
170/4 33,55977,586120,807163,236205,267244,422282,270318,854357,453397,970443,418493,840515,503
42/48 315,795320,390335,528326,113339,300370,901358,791352,019363,284373,941369,270382,790369,435
42 44,02743,22142,42941,65239,15537,84836,58438,59940,51745,44850,42249,18842,342
43 ------3,624---1,007--
430/8 ------3,624---1,007--
44 19424819511511452330153716654--
440/4 19424819511511452330153716654--
45 24,65519,29531,61722,34923,26427,84312,8526,24217,04615,59810,71926,73618,464
450/3 24,65519,29531,61722,34923,26424,91812,8526,24217,04615,5987,86226,73618,464
454/9 -----2,925----2,856--
47/48 246,918257,626261,287261,997276,767304,686305,701307,025305,650312,828307,068306,866308,630
Income statement
76A -70--------65--
9900 143,510106,144159,432126,55584,848111,658106,309101,40291,80885,29874,32261,339100,385
630 1,8762,0351,7311,7319173803005,7795,7795,7796,4456,6943,770
635/8 ---2030--10303030-1,500
640/8 1,6481,6461,5431,4231,4181,4121,4001,2201,3851,3761,37391698
9901 139,987102,464156,157123,38182,483109,866104,60994,39284,61478,11366,47453,72995,017
75/76B ---------063140
75 ---------063140
65/66B 8,61212,41212,02716,44511,16210,90713,73417,01917,98018,65921,14021,45336,536
65 8,61212,41212,02716,44511,16210,90713,73417,01917,98018,65921,14021,45336,536
9903 131,37590,052144,130106,93671,32198,95890,87577,37466,63359,45445,40532,30758,521
67/77 37,68624,99941,72029,93220,89527,25825,33421,87824,78317,89913,3949,31015,107
9904 93,68965,053102,41177,00450,42671,70165,54055,49641,85041,55532,01022,99843,414
789 ----6,316--------
689 ------------6,316
9905 93,68965,053102,41177,00456,74171,70165,54055,49641,85041,55532,01022,99837,098
Appropriation of the result
9906 94,49065,942103,29977,78857,48472,44266,28256,23742,20441,96633,02323,62437,098
14P 802889888784742--------
791/2 1,00029,95645,8504,0004,0003,0003,0003,0002,000----
691/2 93,68065,000102,41076,90056,70071,70065,54055,49641,85040,00031,00021,00034,860
6920 ------------1,860
6921 93,68065,000102,41076,90056,70071,70065,54055,49641,85040,00031,00021,00033,000
694/7 1,00030,09645,8504,0004,0003,0003,0003,0001,6121,6121,6121,6121,612
694 1,00030,09645,8504,0004,0003,0003,0003,0001,6121,6121,6121,6121,612
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 29-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 abbreviated format 29-06-2026 2026-00211271 PDF
31-12-2024 abbreviated format 01-07-2025 2025-00207459 PDF
31-12-2023 abbreviated format 02-07-2024 2024-00195462 PDF
31-12-2022 abbreviated format 03-07-2023 2023-00197599 PDF
31-12-2021 abbreviated format 11-07-2022 2022-20175204 PDF
31-12-2020 abbreviated format 06-07-2021 2021-32000214 PDF
31-12-2019 abbreviated format 06-07-2020 2020-26800386 PDF
31-12-2018 abbreviated format 23-07-2019 2019-36900140 PDF
31-12-2017 abbreviated format 18-07-2018 2018-34700518 PDF
31-12-2016 abbreviated format 03-07-2017 2017-26300512 PDF
31-12-2015 abbreviated format 19-07-2016 2016-32900139 PDF
31-12-2014 abbreviated format 23-07-2015 2015-33400117 PDF
31-12-2013 abbreviated format 28-08-2014 2014-49500144 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202120202019201820172016201520142013
09830011,4731,3910000027,396906,316
50,987-17,39430,0404,936-34,41447,14027,8397,335-5,1266,558-16,552-19,724-
65.7%59.2%54.4%49.9%43.3%37.5%31.9%26.2%20.5%15.9%11.5%7.9%5.8%
13.9%11.2%18.8%15.7%12.1%19.4%21.8%23.3%22.5%28.5%30.2%30.4%80.1%
9.1%6.6%10.2%7.9%5.2%7.3%6.9%6.1%4.6%4.5%3.5%2.4%4.6%

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets-€983--€11,473
€1,876€2,035€1,731€1,731€917

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on DEVA PHARMA

The operating result for 2025 is 37% higher than in 2024. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total falls from 40.6% to 34.1%. Equity is higher and debt is lower.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure